At a glance
ClinicalIndex Comparison RecordN/ACompleted· 205 enrolled
Drug / intervention
Primary total knee replacement (Scorpio NRG CR Total Knee System)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Scorpio NRG Prospective, Open-label, Post-market International Multicentre Outcome Study
In Brief
A clinical study evaluating Primary total knee replacement (Scorpio NRG CR Total Knee System) for Arthroplasty, Replacement, Knee. Completed, enrolled 205 participants across 5 sites in 4 countries.
Detailed Summary
The purpose of this study is to collect basic function, radiographic and patient satisfaction data for observation and analysis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthroplasty, Replacement, Knee
CountriesAustria, Germany, Netherlands, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2009
First PostedAug 2015
Primary CompletionFeb 2020
TodayJul 2026
First PostedAug 17, 2015
Enrollment StartMay 18, 2009
Primary CompletionFeb 10, 2020
TodayJul 2, 2026
Enrollment to primary: 10.7 yearsPosted 10.9 years ago
Interventions
Primary total knee replacement (Scorpio NRG CR Total Knee System)device
Scorpio NRG CR Total Knee System